BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26403752)

  • 1. [Application of Clavien-Dindo classification for comparing complications of three endoscopic procedures for benign prostatic hyperplasia].
    Cai F; Chen C; Zhnag J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1344-8. PubMed ID: 26403752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observation of complications assessed by Clavien-Dindo classification in different endoscopic procedures of benign prostatic hyperplasia: An observational study.
    Pan TT; Li SQ; Dai Y; Qi JX
    Medicine (Baltimore); 2023 Jan; 102(2):e32691. PubMed ID: 36637957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.
    Prudhomme T; Marquette T; Péré M; Patard PM; Michiels C; Sallusto F; Rigaud J; Glémain P; Kamar N; Blancho G; Soulié M; Rischmann P; Karam G; Gamé X; Robert G; Branchereau J
    J Endourol; 2020 Feb; 34(2):184-191. PubMed ID: 31588793
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.
    Wilson LC; Gilling PJ; Williams A; Kennett KM; Frampton CM; Westenberg AM; Fraundorfer MR
    Eur Urol; 2006 Sep; 50(3):569-73. PubMed ID: 16704894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Clinical Efficacy and Safety Profile of Transurethral Resection of Prostate Versus Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia.
    Liu Z; Li YW; Wu WR; Lu Q
    Urology; 2017 May; 103():198-203. PubMed ID: 28188760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.
    He G; Sun C; Shu Y; Wang B; Du C; Chen J; Wen J
    Int J Surg; 2020 Jul; 79():217-221. PubMed ID: 32447004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A matched-pair analysis of patients with medium-sized prostates (50 cc) treated for male LUTS with HoLEP or TURP.
    Magistro G; Westhofen T; Stief CG; Weinhold P
    Low Urin Tract Symptoms; 2020 May; 12(2):117-122. PubMed ID: 31573756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.
    Li Z; Chen P; Wang J; Mao Q; Xiang H; Wang X; Wang X; Zhang X
    Medicine (Baltimore); 2016 Jun; 95(24):e3862. PubMed ID: 27310968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of Holmium Laser Enucleation of the Prostate over Transurethral Resection of the Prostate in a Matched-Pair Analysis of Bleeding Complications Under Various Antithrombotic Regimens.
    Westhofen T; Schott M; Keller P; Tamalunas A; Stief CG; Magistro G
    J Endourol; 2021 Mar; 35(3):328-334. PubMed ID: 32940051
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy and complications of transurethral resection of the prostate versus plasmakinetic enucleation of the prostate.
    Yang CY; Chen GM; Wu YX; Zhang WJ; Wang J; Chen PP; Lou ZY
    Eur J Med Res; 2023 Feb; 28(1):83. PubMed ID: 36805825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral bipolar plasmakinetic resection combined with 2 μm continuous wave laser vaporization: a new method for the treatment of large volume benign prostatic hyperplasia.
    Liao N; Yu J
    Photomed Laser Surg; 2012 Jun; 30(6):320-4. PubMed ID: 22472069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holmium laser enucleation of the prostate is effective in the treatment of symptomatic benign prostatic hyperplasia of any size including a small prostate.
    Lee MH; Yang HJ; Kim DS; Lee CH; Jeon YS
    Korean J Urol; 2014 Nov; 55(11):737-41. PubMed ID: 25405016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holmium Laser enucleation of the prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP).
    Barboza LE; Malafaia O; Slongo LE; Meyer F; Nassif PA; Tabushi FI; Wendler E; Beraldi RA
    Rev Col Bras Cir; 2015 Jun; 42(3):165-70. PubMed ID: 26291257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters.
    Pathak RA; Broderick GA; Igel TC; Petrou SP; Young PR; Wehle MJ; Heckman MG; Diehl NN; Vargas ER; Shah K; Thiel DD
    Urology; 2017 Jan; 99():186-191. PubMed ID: 27771424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A meta-analysis of holmium laser enucleation of the prostate for benign prostatic hyperplasia].
    Zhao CB; Li JC; Yuan PQ; Hong YQ; Lu B; Zhao SC
    Zhonghua Nan Ke Xue; 2011 Dec; 17(12):1112-20. PubMed ID: 22235682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients.
    Kuntz RM; Ahyai S; Lehrich K; Fayad A
    J Urol; 2004 Sep; 172(3):1012-6. PubMed ID: 15311026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.